Estrosas, Baby Girl .
HRN: 23-70-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/14/2023
09/20/2023
PO
4ml
Q8
AGE With Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes